This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Exelixis Inc (EXEL)

: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 37.17M 25.11M 31.34M 47.45M
Cost of Sales 3.90M 2.04M 1.12M 0.00
Gross Operating Profit 33.28M 23.07M 30.22M 47.45M
Selling, General, and Administrative Expenses 57.30M 50.83M 50.96M 31.84M
Research & Development 96.35M 189.10M 178.76M 128.88M
Operating Income before D & A (EBITDA) -120.38M -216.86M -199.50M -113.27M
Depreciation & Amortization 26.44M 31.93M 29.44M 20.47M
Interest Income 412.00K 4.34M 1.22M 1.99M
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -147.45M -252.04M -228.95M -140.92M
Interest Expense 48.67M 48.61M 45.35M 27.09M
Pre-Tax Income -196.12M -300.65M -274.29M -168.01M
Income Taxes 55.00K -182.00K -96.00K 107.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -169.74M -268.54M -244.76M -147.65M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -169.74M -268.54M -244.76M -147.65M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -169.74M -268.54M -244.76M -147.65M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-168.69M -260.95M -243.53M -138.47M
Preferred Dividends
Net Income Available To Common -169.74M -268.54M -244.76M -147.65M
Basic EPS from Continuing Ops. -0.81 -1.38 -1.33 -0.92
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.81 -1.38 -1.33 -0.92
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.81 -1.38 -1.33 -0.92
Basic Normalized Net Income/Share -0.81 -1.34 -1.32 -0.86
EPS fr Continuing Ops. -0.81 -1.38 -1.33 -0.92
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.81 -1.38 -1.33 -0.92
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.81 -1.38 -1.33 -0.92
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.81 -1.34 -1.32 -0.86
Dividends Paid per Share 0.00 0.00 0.00 0.00
EXEL News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for EXEL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 3 3 3
Moderate Buy 0 0 0 0
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET EXEL ANALYST REPORT

EXEL Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs